Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1636
https://www.valueinhealthjournal.com/article/S1098-3015(14)03566-9/fulltext
Title :
Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03566-9&doi=10.1016/j.jval.2014.08.1636
First page :
A522
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1112